M.H. Otten - Concepedia

Author

M.H. Otten

Erasmus MC - Sophia Children’s Hospital ORCID

Also Known As

M H Otten, M Otten, M. H. OTTEN, M. H. Otten, M. Otten, M.H. Otten, MARIEKE H. OTTEN, Marieke H Otten, Marieke H. Otten, Marieke Otten

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC - Sophia Children’s Hospital Emma Kinderziekenhuis Radboud University Nijmegen Radboud University Medical Center Juliana Kinderziekenhuis

About

M.H. Otten is an author at Erasmus MC - Sophia Children’s Hospital specializing in medicine, health sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	408
2	Health Sciences	4	4	203
3	Public Health	1	1	39
4	Anesthesia	1	1	12
5	Biochemistry	1	1	89

M.H. Otten

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis Dirk Holzinger, Michael Frosch, Astrid Kastrup, Annals of the Rheumatic Diseases	2012	160
Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis M.H. Otten, Femke H. M. Prince, Wineke Armbrust, JAMA	2011	143
RAISED TOTAL THYROXINE AND FREE THYROXINE INDEX BUT NORMAL FREE THYROXINE G Hennemann, E. P. Krenning, M.H. Otten, The Lancet Thyroid Hormone	1979	123
Sulfation Preceding Deiodination of Iodothyronines in Rat Hepatocytes M.H. Otten, J. A. Mol, T.J. Visser Science Animals IodothyroninesGlucuronic AcidToxicological MechanismOxidative StressToxicology	1983	89
Long‐term safety of tegaserod in patients with constipation‐predominant irritable bowel syndrome Gervais Tougas, W.J. Snape, M.H. Otten, Alimentary Pharmacology & Therapeutics Pain DisordersGastrointestinal PharmacologyGastroenterologyPharmacotherapyDigestive Tract	2002	77
MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis Janneke Anink, Lisette W. A. van Suijlekom‐Smit, M.H. Otten, Arthritis Research & Therapy ImmunologyPathologyPsoriatic ArthritisInflammationRheumatoid Disorder	2015	77
NALOXONE IN SHOCK R. Dirksen, M.H. Otten, Gordoń Wood, The Lancet NeuropharmacologyNaloxone In ShockPharmacotherapyDrug OverdoseMedicine	1980	75
Tumor Necrosis Factor-blocking Agents for Children with Enthesitis-related Arthritis — Data from the Dutch Arthritis and Biologicals in Children Register, 1999–2010 M.H. Otten, Femke H. M. Prince, Marinka Twilt, The Journal of Rheumatology	2011	72
Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register M.H. Otten, Femke H. M. Prince, Janneke Anink, Annals of the Rheumatic Diseases	2012	57
Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register M.H. Otten, Janneke Anink, Femke H. M. Prince, Annals of the Rheumatic Diseases	2014	55

Page 1